Subramanya S. Kumar

Stevenage, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Challenges and Insights from the Mepolizumab Pregnancy Exposure Study.

Challenges and Insights from the Mepolizumab Pregnancy Exposure Study.

Journal: Drug safety

Published: February 03, 2026

SABA prescriptions and asthma management practices in Singapore: results from a cross-sectional, observational SABINA III study.

SABA prescriptions and asthma management practices in Singapore: results from a cross-sectional, observational SABINA III study.

Journal: BMJ open

Published: June 10, 2024

Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial.

Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial.

Journal: ERJ open research

Published: October 06, 2023

Pharmacokinetics and safety of inhaled oxytocin compared with intramuscular oxytocin in women in the third stage of labour: A randomized open-label study.

Pharmacokinetics and safety of inhaled oxytocin compared with intramuscular oxytocin in women in the third stage of labour: A randomized open-label study.

Journal: British journal of clinical pharmacology

Published: November 11, 2022

Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial.

Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial.

Journal: Thorax

Published: October 14, 2021

Evaluation of Dynamic Contrast-Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study.

Evaluation of Dynamic Contrast-Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study.

Journal: Journal of magnetic resonance imaging : JMRI

Published: November 12, 2020

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial.

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial.

Journal: Respiratory research

Published: September 26, 2019

Identification, preclinical profile, and clinical proof of concept of an orally bioavailable pro-drug of miridesap.

Identification, preclinical profile, and clinical proof of concept of an orally bioavailable pro-drug of miridesap.

Journal: British journal of pharmacology

Published: July 09, 2019

Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects.

Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions

Published: January 15, 2019

The effects of GSK2981710, a medium-chain triglyceride, on cognitive function in healthy older participants: A randomised, placebo-controlled study.

The effects of GSK2981710, a medium-chain triglyceride, on cognitive function in healthy older participants: A randomised, placebo-controlled study.

Journal: Human psychopharmacology

Published: October 12, 2018

Defect healing and enhanced nucleation of carbon nanotubes by low-energy ion bombardment.

Defect healing and enhanced nucleation of carbon nanotubes by low-energy ion bombardment.

Journal: Physical review letters

Published: November 07, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026